Angelini Pharma has entered into an exclusive global option agreement with Sovargen, a South Korean biotechnology firm, to license the development and commercialization rights...
URGENT UPDATE: Angelini Pharma has just announced the signing of an exclusive global option agreement with Sovargen for the development and commercialization of a...